MicroRNA in vitro diagnostics using immunoassay analyzers

Clinical Chemistry

Volumn 61, Issue 4, 2015, Pages 600-607

  Kappel, Andreas ^a   Backes, Christina ^b   Huang, Yiwei ^a   Zafari, Sachli ^b   Leidinger, Petra ^b   Meder, Benjamin ^c   Schwarz, Herbert ^d   Gumbrecht, Walter ^a   Meese, Eckart ^b   Staehler, Cord F ^a   Keller, Andreas ^b  

^a SIEMENS AG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d Siemens Healthcare Diagnostics Products GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTER DERIVATIVE; MICRORNA; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; STREPTAVIDIN; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA RNA HYBRIDIZATION; GOLD STANDARD; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; IN VITRO STUDY; LIMIT OF DETECTION; NORMAL HUMAN; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; BLOOD; DEVICES; DIAGNOSTIC USE; EVALUATION STUDY; GENETICS; PROCEDURES;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; MICRORNAS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84925799414     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.232165     Document Type: Article

References (26)

1. Friedman RC, Farh KK, Burge C.B., Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92-105.
2. Lu M, Zhang Q, Deng M., Miao J, Guo Y, Gao W., Cui Q. An analysis of human microRNA and disease associations. PLoS One 2008; 3:e3420.
3. Osbourne A, Calway T, Broman M., McSharry S, Earley J, Kim GH. Downregulation of connexin43 by microRNA-130 a in cardiomyocytes results in cardiac arrhythmias. J Mol Cell Cardiol 2014; 74:53-63.
4. Okada N, Lin CP, Ribeiro M.C., Biton A., Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 2014; 28: 438-50.
5. Long JM, Ray B, Lahiri DK. MicroRNA-339-5p down-regulates protein expression of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 2014; 289:5184-98.
6. Keller A, Leidinger P, Bauer A., Elsharawy A, Haas J, Backes C., et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011; 8:841-3.
7. Keller A, Leidinger P, Borries A., Wendschlag A, Wucherpfennig F, Scheffler M., et al. miRNAs in lung cancer: studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009; 9:353.
8. Keller A, Leidinger P, Gislefoss R., Haugen A, Langseth H, Staehler P., et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8:506-16.
9. Keller A, Leidinger P, Lange J., Borries A, Schroers H, Scheffler M., et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009; 4:e7440.
10. Keller A, Leidinger P, Steinmeyer F., Stahler C, Franke A, Hemmrich-Stanisak G, et al. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 2014; 20:295-303.
11. Leidinger P, Backes C, Deutscher S., Schmitt K, Mueller SC, Frese K, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 2013; 14: R78.
12. Leidinger P, Keller A, Backes C., Huwer H, Meese E. MicroRNA expression changes after lung cancer resection: a follow-up study. RNA Biol 2012; 9:900-10.
13. Leidinger P, Keller A, Borries A., Huwer H, Rohling M, Huebers J., et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011; 74:41-7.
14. Leidinger P, Keller A, Borries A., Reichrath J, Rass K, Jager S.U., et al. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 2010; 10:262.
15. Hausler SF, Keller A, Chandran P.A., Ziegler K., Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 2010; 103:693-700.
16. Santos JI, Teixeira AL, Dias F, Mauricio J., Lobo F, Morais A, Medeiros R. Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. Tumour Biol 2014; 35:7105-13.
17. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel P.L., Kahmann L., Loehberg CR, et al. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012; 7:e29770.
18. Schultz NA, Dehlendorff C, Jensen B.V., Bjerregaard JK, Nielsen KR, Bojesen SE, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 2014; 311:392-404.
19. The worldwide market forin vitro diagnostic (IVD) tests. 8th ed. New York: Kalorama Information; 2012.
20. German Medical Association and Paul Ehrlich Institute. Guidelines for the collection of blood and blood components and the use of blood products (hemotherapy). Cologne (Germany): Deutscher Aerzteverlag; 2007.
21. Guide to the use, preparation and quality control of blood components. Recommendation no. R(95) 15. 15th ed. Strasbourg (France): Council of Europe; 2009.
22. Chen C, Ridzon DA, Broomer A.J., Zhou Z., Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
23. Dwyer R. The ADVIA Centaur infectious disease assays: a technical review. J Clin Virol 2004; 30(SUPPL. 1): S1-5.
24. Boguslawski SJ, Smith DE, Michalak M.A., Mickelson KE, Yehle CO, Patterson WL, Carrico RJ. Characterization of monoclonal antibody to DNA. RNA and its application to immunodetection of hybrids. J Immunol Methods 1986; 89:123-30.
25. Yehle CO, Patterson WL, Boguslawski S.J., Albarella JP, Yip KF, Carrico RJ. A solution hybridization assay for ribosomal RNA from bacteria using biotinylated DNA probes and enzyme-labeled antibodytoDNA: RNA. Mol Cell Probes 1987; 1:177-93.
26. Weeks I, Campbell AK, Woodhead JS. Two-site immunochemiluminometric assay for human alpha 1-fetoprotein. Clin Chem 1983; 29:1480-3.